Trevi Therapeutics, Inc

About

Trevi Therapeutics, Inc., located in New Haven, CT, focuses on the development of Haduvio, an investigational therapy aimed at treating chronic cough conditions. This oral formulation of nalbuphine ER targets the cough reflex, addressing issues related to idiopathic pulmonary fibrosis and refractory chronic cough. With ongoing clinical trials, Trevi aims to provide solutions for patients struggling with chronic cough, which significantly affects their quality of life. Haduvio is notable as it is the first investigational treatment to show meaningful reductions in cough frequency during clinical trials.

Service area

Serves the business city